Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proline-rich protein 23D2 is a protein-coding gene located on chromosome 8 in humans. It is also known as PRR23D1, and shares high sequence similarity with other proline-rich proteins. The protein is classified as a predicted intracellular protein with unknown molecular function and limited characterization in terms of biology or disease involvement. There is currently no evidence that PRR23D2 serves as a therapeutic target, nor are there any drugs known to interact with it or diseases directly linked to its activity. Expression studies and available databases do not ascribe clear molecular functions, classifications, or therapeutic relevance at this time. There is a similarly named gene, PRRT2 (Proline-rich transmembrane protein 2), which is associated with neurological diseases and well-characterized synaptic functions, but PRR23D2 is a distinct and unrelated gene. Some molecular function listings (such as "acyltransferase" or "non-receptor serine/threonine kinase" from mass annotation databases) are potentially erroneous or generic, and do not reflect consensus or specific functional validation for PRR23D2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline-rich protein 23D2 (PRR23D2).